Assessing the mechanisms of cholesteryl ester transfer protein inhibitors

Cholesteryl ester transfer protein (CETP) inhibitors are a new class of therapeutics for dyslipidemia that simultaneously improve two major cardiovascular disease (CVD) risk factors: elevated low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. However,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biochim Biophys Acta Mol Cell Biol Lipids
Autores principales: Zhang, Meng, Lei, Dongsheng, Peng, Bo, Yang, Mickey, Zhang, Lei, Charles, M. Art, Rye, Kerry-Anne, Krauss, Ronald M., Johns, Douglas G., Ren, Gang
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239860/
https://ncbi.nlm.nih.gov/pubmed/28911944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2017.09.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares